<DOC>
	<DOCNO>NCT01715727</DOCNO>
	<brief_summary>The hypothesis study dopaminergic cell death locate basal ganglion brain patient Parkinson 's Disease detect diffusion Magnetic Resonance Imaging , specifically diffusion kurtosis imaging . The preliminary result publish Radiology 2011 . The current study propose investigate follow issue : - validation diagnostic sensitivity specificity - differential diagnosis capability PD PD+ syndrome - prognosis capability In first year , patient Parkinson 's disease recruit outpatient clinic movement disorder ChangGung memorial hospital Linkou , Taiwan . The diffusion parameter basal ganglion compare group healthy control . In second year , patient progressive supranuclear palsy patient multiple system atrophy recruit assessment differential diagnosis . The patient Parkinson 's Disease return assessment disease severity third year , outcome evaluation .</brief_summary>
	<brief_title>Diagnosis Parkinson 's Disease Using Diffusion Magnetic Resonance Imaging</brief_title>
	<detailed_description>Currently exist specific diagnostic test Parkinson 's Disease . Accurate diagnosis great interest reduction health cost disease co-morbidity , improvement effective treatment course avoidance un-necessary intervention . Our preliminary result show superior performance diffusion kurtosis imaging , new development MRI since 2007 , diagnosis Parkinson 's Disease compare conventional diffusion MRI . The study propose validate diagnostic value diffusion kurtosis major basal ganglion region use cross-sectional study ass prognostic value 3-year longitudinal follow-up . Furthermore , iron content well global white matter involvement PD PD plus syndrome patient assess . The difference MRI information PD PD plus syndrome patient address comprehensive manner . One hundred twelve patient Parkinson 's Disease recruit first year follow 3 year . Another 112 healthy control include . This validate diagnosis ass prognosis . Another 30 patient Parkinson 's Disease , 15 patient progressive supranuclear palsy 15 patient multiple system atrophy recruit 2nd year differential diagnosis . The image protocol include diffusion tensor diffusion kurtosis imaging . Susceptibility weight image include iron content estimation . The targeted anatomy include regional change basal ganglion , midbrain well thalamus , global white matter change use tract base spatial statistic . The statistical analysis use receiver operative characteristic assess diagnostic performance , Spearman 's ranked correlation correlation disease severity net reclassification improvement differential diagnosis . The prognostic value determine decline rate quality life . The end point project differentiate patient PD PD plus syndrome , predict clinical outcome use diffusion MRI . Patent application file first year . The analysis medical device software software life cycle process evaluation risk management medical device file end third year .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Parkinsons‟s Disease follow : 112 subject 1 . Patients fulfill National Institute Neurological Disorders Stroke USA ( NINDS ) Diagnostic Criteria Parkinson Disease ( 37 ) `` probable‟ PD , except age onset . 2 . Able tolerate disability `` drugoff '' state , least 12 hour . 3 . Able understand provide sign informed consent . 4 . Early moderate stage define Hohen Yahr stage 13 , subject = 100 Parkinsons‟s Disease severity match : 30 subject 1 . Patients fulfill National Institute Neurological Disorders Stroke USA ( NINDS ) Diagnostic Criteria Parkinson Disease ( 37 ) `` probable‟ PD , except age onset . 2 . Able tolerate disability `` drugoff '' state , least 12 hour . 3 . Able understand provide sign informed consent . 4 . Severity match PSP ( subject = 15 ) /MSA ( subjects= 15 ) , severity judge Hohen Yahr stage Healthy age match control : subject = 112 1 . Healthy subject without clinically significant abnormal laboratory value , and/or clinically significant unstable medical psychiatric illness . 2 . Able understand provide sign informed consent . 3 . Age range gender match Parkinsons‟s Disease follow . Parkinson Plus Syndrome Group M ( Multi System Atrophy , subject = 15 ) : 1 . MSA Patients fulfill NINDS Consensus statement clinical diagnosis probable MSA ( 38 ) 2 . Able tolerate disability `` drugoff '' state , least 12 hour . 3 . Able understand provide sign informed consent 2012/04/20 第二版 14 Parkinson Plus Syndrome Group P ( Progressive Supranuclear Palsy , subject = 15 ) : 1 . PSP Patients fulfill NINDSSPSP Litvan criterion ( 4 ) probable PSP 2 . Able tolerate disability `` drugoff '' state , least 12 hour . 3 . Able understand provide sign informed consent . The following exclusion criterion apply group . 1 . Cardiac pacemaker implantation . 2 . Implantation intracranial metal device . 3 . Significant major systemic disease , renal failure , heart failure , stroke , AMI/unstable angina , poor control diabetes mellitus , poor control hypertension . 4 . Pregnant breast feed woman . 5 . Moderate severer dementia . 6 . Severe dyskinesia 7 . Any documented abnormality brain brain MRI 18FDG PET study , might contribute cognitive function , hydrocephalus encephalomalacia , exclude . Mild cortical atrophy allow . 8 . History intracranial operation , include thalamotomy , pallidotomy , and/or deep brain stimulation . 9 . Significant physical disorder neuropsychiatric disorder . 10 . Except medication parkinsonism relate symptom , subject receive medication pas bloodbrain barrier exclude . 11 . Except medication parkinsonism relate symptom , subject chronically take drug 10 year exclude .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>diffusion kurtosis imaging</keyword>
	<keyword>parkinson disease</keyword>
	<keyword>parkinsonism</keyword>
	<keyword>diagnosis</keyword>
	<keyword>differential diagnosis</keyword>
</DOC>